Anticoagulation Management After Hemorrhagic Stroke in Atrial Fibrillation Patients

Introduction to Anticoagulation Timing

For patients with atrial fibrillation who have experienced a hemorrhagic stroke, anticoagulation should be delayed beyond the acute phase (approximately 48 hours) and probably for at least approximately 4 weeks after the hemorrhagic event, as recommended by the American College of Chest Physicians 1
The decision to restart anticoagulation must balance the risk of recurrent hemorrhagic stroke against the risk of ischemic stroke, considering guidelines from the American Heart Association and the American Stroke Association 1, 2

Evaluate the location of the intracerebral hemorrhage (ICH) - deep ICH locations may have more favorable benefit-risk profiles for anticoagulation resumption compared to lobar hemorrhages, according to the American College of Chest Physicians 1
Consider neuroimaging evidence of cerebral amyloid angiopathy, which increases risk of recurrent ICH, as noted by the American College of Chest Physicians 1
Assess the patient's CHA₂DS₂-VASc score to determine thromboembolic risk, as recommended by the American Heart Association 2

Wait at least 4 weeks after ICH before reinitiating anticoagulation, based on guidelines from the European Society of Cardiology and the American College of Chest Physicians 1, 3
For patients with high thromboembolic risk, the benefit of anticoagulation initiated at 7-8 weeks post-ICH outweighs the bleeding risk, although specific timing may vary based on individual patient factors 1

For patients with non-valvular AF and stroke or TIA, direct oral anticoagulants (DOACs) such as apixaban, dabigatran, edoxaban, or rivaroxaban are recommended in preference to warfarin by the American Heart Association 2
For patients with mechanical heart valves or moderate to severe mitral stenosis, warfarin remains the anticoagulant of choice, as recommended by the American College of Cardiology and the American Heart Association 2

In ICH survivors at high risk of recurrent ICH (e.g., those with probable cerebral amyloid angiopathy), consider left atrial appendage occlusion as an alternative to anticoagulation, as suggested by the American College of Chest Physicians 1
For patients with end-stage renal disease or on dialysis, warfarin or dose-adjusted apixaban may be reasonable options, according to the American Heart Association 2
Patients with uncontrolled hypertension should have blood pressure optimized before restarting anticoagulation, as recommended by the European Society of Cardiology 3

Perform follow-up neuroimaging before initiating anticoagulation to ensure stability of the hemorrhage, as recommended by clinical guidelines from the American College of Radiology 4
Monitor for signs of recurrent bleeding after anticoagulation initiation, and ensure optimal blood pressure control to minimize risk of recurrent hemorrhage, as suggested by the European Society of Cardiology 3

Avoid very early anticoagulation (<48 hours) after hemorrhagic stroke as this increases risk of expansion, as warned by the American College of Chest Physicians 1, 5
Do not use heparinoids as bridging therapy in the acute phase of stroke as they increase the risk of symptomatic intracranial hemorrhage without net benefit, according to the American College of Chest Physicians 1